Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease | Nature Communications
Frontiers | Selective Detection of Misfolded Tau From Postmortem Alzheimer's Disease Brains
Tau-targeting therapy in Alzheimer's disease: critical advances and future opportunities
Blood test method may predict Alzheimer's protein deposits in brain | National Institutes of Health (NIH)
Total-TAU cellular HTRF kit | Cisbio
A blood test for Alzheimer's markers for Tau protein gets closer | Healthcare Purchasing News
Alzheimer's Blood Test Measures Levels of Phosphorylated Tau | Technology Networks
Does beta-amyloid cause Alzheimer's, or is something else to blame? : Shots - Health News : NPR
Experimental evidence for the age dependence of tau protein spread in the brain | Science Advances
New blood test to diagnose Alzheimer's disease via brain-derived protein - Advanced Science News
Tau Aggregation In Vitro - QPS Neuropharmacology
Tau Protein a Better Marker of Alzheimer's Progression Than Amyloid Beta - Neuroscience News
New Blood Test Differentiates Neurodegeneration in Alzheimer's Disease From Other Dementias - Neuroscience News
C2N launches blood test for Alzheimer's research
Tau protein—not amyloid—may be key driver of Alzheimer's symptoms | Science | AAAS
Alzheimer 'Tau' Protein Far Surpasses Amyloid in Predicting Toll on Brain Tissue | UC San Francisco
Brain Sciences | Free Full-Text | Pharmacological Modulators of Tau Aggregation and Spreading
Phosphorylated Tau Protein Blood Test Distinguishes Alzheimer's Disease from Other Neurological Disorders - molecular-diagnostics - mobile.Labmedica.com
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts - The Lancet Neurology
Tau protein could be key to an Alzheimer's blood test
Liquid-liquid phase separation induces pathogenic tau conformations in vitro | Nature Communications
A Guide To Tau Proteins & Tauopathies - Assay Genie
Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes: Molecular Therapy
JCM | Free Full-Text | Diagnostic Utility of Selected Serum Dementia Biomarkers: Amyloid β-40, Amyloid β-42, Tau Protein, and YKL-40: A Review
Lentiviral Delivery of the Human Wild-type Tau Protein Mediates a Slow and Progressive Neurodegenerative Tau Pathology in the Rat Brain: Molecular Therapy
Alzheimer 'Tau' Protein Far Surpasses Amyloid in Predicting Toll on Brain Tissue | UC San Francisco
